[The use of cyproteronacetate in patients with adrenogenital syndrome caused by C-21 hydroxylase deficiency].
D000312:Adrenal Hyperplasia, Congenital / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology; D000726:Androgen Antagonists; D002675:Child, Preschool; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000172:deficiency*; D011629:Puberty, Precocious / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology
D000726:Androgen Antagonists; D003907:Dexamethasone; D006899:Mixed Function Oxygenases
Cyproteronacetát alkalmazása C--21-hydroxylase defektus okozta adrenogenitalis syndromás betegekben